Lotus Pharmaceutical Co., Ltd. (1795.TW)

TWD 220.5

(-3.08%)

Operating Income Summary of Lotus Pharmaceutical Co., Ltd.

  • Lotus Pharmaceutical Co., Ltd.'s latest annual operating income in 2023 was 4.9 Billion TWD , up 13.51% from previous year.
  • Lotus Pharmaceutical Co., Ltd.'s latest quarterly operating income in 2024 Q1 was 1.45 Billion TWD , up 915.9% from previous quarter.
  • Lotus Pharmaceutical Co., Ltd. reported an annual operating income of 4.31 Billion TWD in 2022, up 96.24% from previous year.
  • Lotus Pharmaceutical Co., Ltd. reported an annual operating income of 2.2 Billion TWD in 2021, up 34.43% from previous year.
  • Lotus Pharmaceutical Co., Ltd. reported a quarterly operating income of 1.63 Billion TWD for 2024 Q2, up 12.11% from previous quarter.
  • Lotus Pharmaceutical Co., Ltd. reported a quarterly operating income of 143.39 Million TWD for 2023 Q4, down -91.55% from previous quarter.

Annual Operating Income Chart of Lotus Pharmaceutical Co., Ltd. (2023 - 2009)

Historical Annual Operating Income of Lotus Pharmaceutical Co., Ltd. (2023 - 2009)

Year Operating Income Operating Income Growth
2023 4.9 Billion TWD 13.51%
2022 4.31 Billion TWD 96.24%
2021 2.2 Billion TWD 34.43%
2020 1.63 Billion TWD 34.68%
2019 1.21 Billion TWD 170.95%
2018 448.68 Million TWD -14.22%
2017 523.08 Million TWD 114.04%
2016 244.38 Million TWD -45.55%
2015 448.83 Million TWD 203.12%
2014 -435.25 Million TWD -1620.97%
2013 -25.29 Million TWD 87.57%
2012 -203.4 Million TWD -39.45%
2011 -145.86 Million TWD -740.83%
2010 22.76 Million TWD -43.62%
2009 40.37 Million TWD 0.0%

Peer Operating Income Comparison of Lotus Pharmaceutical Co., Ltd.

Name Operating Income Operating Income Difference
Grape King Bio Ltd 2.49 Billion TWD -96.38%
Standard Chem & Pharm CO., LTD. 1.25 Billion TWD -289.261%
Maywufa Company Ltd. 211.01 Million TWD -2223.46%
ScinoPharm Taiwan, Ltd. 314.49 Million TWD -1459.009%
LIWANLI Innovation Co., Ltd. - TWD -Infinity%
YungShin Global Holding Corporation 929.61 Million TWD -427.418%
PhytoHealth Corporation -121.67 Million TWD 4129.473%
SCI Pharmtech, Inc. 160.3 Million TWD -2958.604%
Formosa Laboratories, Inc. 674.97 Million TWD -626.389%
PharmaEssentia Corporation - TWD -Infinity%
Bora Pharmaceuticals Co., LTD. 5.24 Billion TWD 6.595%